BIOMAT Database Logo BIOMAT Database Logo

trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages. 1993

M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Division of Experimental Oncology A, Istituto Nazionale Tumori, Milan, Italy.

Forty-three fresh tumor specimens of human neuroblastoma belonging to different clinical stages were analyzed for the expression of 2 proto-oncogenes: trk, which encodes a tyrosine-kinase receptor for nerve growth factor (NGF) and ret, another receptor-type tyrosine kinase whose ligand is unknown. The mRNA expression of the trk gene was detected in 67.4% of cases, with increased frequency in I, II and IVs Evans' stages and in patients with favorable prognosis according to the Shimada classification. Moreover, trk expression inversely correlated with Nmyc-gene amplification. ret mRNA was found in 36.8% of cases and equally distributed in the different stages. In addition, ngfR (low-affinity NGF receptor)-gene expression was present in 9 out of 25 cases. The simultaneous presence of mRNA related to both forms of the NGF receptor, while not proving the presence of a functional receptor, indicates the existence of a sub-set of neuroblastoma cells potentially responsive to NGF.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009414 Nerve Growth Factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. Neurite Outgrowth Factor,Neurite Outgrowth Factors,Neuronal Growth-Associated Protein,Neuronotrophic Factor,Neurotrophic Factor,Neurotrophic Factors,Neurotrophin,Neurotrophins,Growth-Associated Proteins, Neuronal,Neuronal Growth-Associated Proteins,Neuronotrophic Factors,Neurotrophic Protein,Neurotrophic Proteins,Proteins, Neuronal Growth-Associated,Factor, Neurite Outgrowth,Factor, Neuronotrophic,Factor, Neurotrophic,Factors, Nerve Growth,Factors, Neurite Outgrowth,Factors, Neuronotrophic,Factors, Neurotrophic,Growth Associated Proteins, Neuronal,Growth-Associated Protein, Neuronal,Neuronal Growth Associated Protein,Neuronal Growth Associated Proteins,Outgrowth Factor, Neurite,Outgrowth Factors, Neurite,Protein, Neuronal Growth-Associated
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA

Related Publications

M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
September 1990, Oncogene,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Increased expression of trk proto-oncogene by gamma-interferon in human neuroblastoma cell lines.
February 1994, Japanese journal of cancer research : Gann,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Expression of ret proto-oncogene in human neuroblastomas.
April 1990, Japanese journal of cancer research : Gann,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
[Human ret proto-oncogene].
August 1990, Nihon rinsho. Japanese journal of clinical medicine,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Expression of the RET proto-oncogene in human embryos.
December 1998, American journal of medical genetics,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
The RET proto-oncogene in human cancers.
November 2000, Oncogene,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells.
February 1991, Oncogene,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Molecular and biochemical characterization of the human trk proto-oncogene.
January 1989, Molecular and cellular biology,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
RET proto-oncogene in the development of human cancer.
January 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M G Borrello, and I Bongarzone, and M A Pierotti, and R Luksch, and M Gasparini, and P Collini, and S Pilotti, and M G Rizzetti, and P Mondellini, and B De Bernardi
Human TRK proto-oncogene maps to chromosome 1q32-q41.
September 1990, Oncogene,
Copied contents to your clipboard!